24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Genomics, technology, bioinformatics 0<br />

Oligo-Array (Agilent) was created . Multiple probes on this array spanning<br />

the amplified region <strong>of</strong> exon 2 <strong>of</strong> the dystrophin gene.<br />

In a next step Array-CGH data will provide a basic for the design <strong>of</strong><br />

PCR systems for exact determination <strong>of</strong> the amplification limits.<br />

P08.26<br />

Role <strong>of</strong> the kinase DYRK1A in cerebral cortex development:<br />

effects on the transcriptome<br />

E. Balducci 1,2 , M. J. Barallobre 1,2 , M. C. Ruiz de Villa 3 , A. Sánchez 3 , M. L. Arbonés<br />

1,2 ;<br />

1 Center for Genomic Regulation (CRG), <strong>Barcelona</strong>, Spain, 2 Centre for Biomedical<br />

Research on Rare Diseases (CIBERER), <strong>Barcelona</strong>, Spain, 3 Statistics Department,<br />

University <strong>of</strong> <strong>Barcelona</strong>, <strong>Barcelona</strong>, Spain.<br />

DYRK1A is a dual-specificity protein kinase involved in brain development<br />

. <strong>Human</strong> DYRK1A is located in the Down Syndrome (DS) Critical<br />

Region <strong>of</strong> chromosome 21 and its overexpression has been associated<br />

to the neurological defects observed in DS . Nevertheless, DYRK1A<br />

function at the molecular level remains poorly understood . As DYRK1A<br />

substrates include several transcription factors, we have analyzed the<br />

impact <strong>of</strong> Dyrk1a dose reduction on the transcriptome <strong>of</strong> mouse cerebral<br />

cortex at postnatal day 0 (P0) and 7 (P7) . To this end, global gene<br />

expression <strong>of</strong> Dyrk1a+/- and Dyrk1a+/+ cortices were compared using<br />

Affymetrix chips .<br />

Microarray results revealed deep changes in gene expression extending<br />

into the set <strong>of</strong> 3169 genes analyzed . Among those, 22% and 5%<br />

showed different expression levels between genotypes at P0 and P7<br />

respectively (adj-p2 . Gene Ontology analysis revealed enrichment in transporters within<br />

the down-regulated genes and in DNA binding molecules within the upregulated<br />

genes both, at P0 and at P7 . Among the genes deregulated<br />

between genotypes, 61 were common to both developmental stages .<br />

Interestingly, their regulation showed a similar trend at P0 and P7 but<br />

always opposite to the developmental trend (defined by the expression<br />

<strong>of</strong> such genes in Dyrk1a+/+ mice at P7 vs P0) .<br />

These results suggest that DYRK1A plays a pivotal role in cerebral<br />

cortex development acting on the regulation <strong>of</strong> the transcriptome .<br />

P08.27<br />

Re-examining the human genome<br />

R. J. Kinsella, I. Barnes, C. Snow, A. Frankish, J. Mudge, L. Wilming, J. Loveland,<br />

D. Carvalho-Silva, J. Rajan, E. Hart, L. Gordon, J. Gilbert, S. Trevanion, T.<br />

Hubbard, J. L. Harrow;<br />

Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.<br />

Recent improvements in sequencing technologies enable the routine<br />

sequencing <strong>of</strong> large complex genomes . However the annotation <strong>of</strong><br />

such genomes is still complex and there is no higher eukaryote that<br />

has all its coding sequences predicted to 100% accuracy . The HA-<br />

VANA group (http://www .sanger .ac .uk/HGP/havana/) at the Wellcome<br />

Trust Sanger Institute is involved in manually annotating all the coding<br />

transcripts within the human genome through various international collaborations<br />

. The team is involved in the scale up <strong>of</strong> the ENCODE pilot<br />

gene annotation project (GENCODE) to the whole human genome .<br />

The project includes seven other partner institutes and will integrate<br />

computational approaches, expert manual annotation and targeted<br />

experimental approaches to generate a reference gene set . This will<br />

include analysis <strong>of</strong> pseudogenes, experimental validation <strong>of</strong> putative/<br />

novel genes and examination <strong>of</strong> the protein-coding potential <strong>of</strong> genes<br />

using comparative and structural analysis .<br />

In addition, the Havana group collaborates with RefSeq at NCBI,<br />

UCSC and Ensembl to produce a core set <strong>of</strong> human and mouse coding<br />

genes for the Consensus CDS (CCDS) project . Any CCDS candidate<br />

transcripts where there is disagreement between WTSI/EBI and NCBI<br />

annotation are manually re inspected, discussed and, where possible,<br />

an accord is reached on a structure (18293 human CCDS agreed to<br />

date) . The end result is a combined, non-redundant gene set agreed<br />

by several <strong>of</strong> the major genome centers .<br />

All annotation is displayed on the Vertebrate Genome Annotation<br />

(VEGA) database, a central repository for high quality manual annotation<br />

<strong>of</strong> finished vertebrate genome sequence with a three monthly<br />

release cycle (http://vega .sanger .ac .uk/index .html) .<br />

P08.28<br />

An in vivo unbiased screen for enhancer activity using<br />

lentivector-mediated transgenesis<br />

M. Friedli1 , I. Barde2 , C. Attanasio1 , M. Arcangeli1 , A. Quazzola2 , S. Verp2 , F.<br />

Spitz3 , J. Zakany4 , D. Duboule4,2 , D. Trono2 , S. E. Antonarakis1 ;<br />

1University <strong>of</strong> Geneva, Department <strong>of</strong> Genetic Medicine and Development,<br />

Geneva, Switzerland, 2EPFL, School <strong>of</strong> Life Sciences, Lausanne, Switzerland,<br />

3 4 EMBL, Heidelberg, Germany, University <strong>of</strong> Geneva, Department <strong>of</strong> Zoology<br />

and Animal Biology, Geneva, Switzerland.<br />

Finding sequences that control spatial and temporal expression <strong>of</strong><br />

genes is important to understand genome function . Here, we present<br />

an in vivo screen for enhancers in a contiguous 200-kilobase DNA<br />

fragment using lentivector-mediated transgenesis . Previous studies<br />

have used evolutionary conservation as an indicator <strong>of</strong> regulatory<br />

potential, but increasing evidence suggests that this criterion systematically<br />

overlooks functional sequences . We thus designed our study<br />

without any bias towards a particular sequence feature . We chose a<br />

mouse BAC corresponding to a region <strong>of</strong> Hsa21 because it contains<br />

the olig1 and olig2 genes that are expressed specifically in the CNS.<br />

In order to screen this fragment systematically for enhancer activity,<br />

we generated a library <strong>of</strong> 121 overlapping clones (sizes: 2-4kb) in a<br />

LacZ reporter lentiviral construct containing a minimal promoter . We<br />

generated lentivectors individually for each segment and injected them<br />

in pools <strong>of</strong> 10 or 20 in mouse oocytes . LacZ staining was performed<br />

on E11 embryos to identify expression patterns. The first six pools<br />

tested yielded 60 <strong>of</strong> 242 LacZ positive embryos with ~2 .5 transgenes<br />

per embryo. To date, 7 fragments <strong>of</strong> 52 assessed were identified that<br />

potentially contain gene expression regulators. To confirm regulatory<br />

activity, 4 sequences were re-injected individually, 2 (one evolutionary<br />

conserved) <strong>of</strong> which were confirmed as tissue specific enhancers with<br />

stainings in the spinal chord and trigeminal ganglion compatible with<br />

olig expression . The method could be scaled up to cover large chromosomal<br />

regions, and determine what fraction <strong>of</strong> the constrained and<br />

non-constrained genome has regulatory potential .<br />

P08.29<br />

Enhanced workflow for sequencing PCR products by capillary<br />

electrophoresis<br />

P. Kotturi, E. Currie-Fraser, S. Pickrell, M. Johnson, P. McNamara;<br />

Applied Biosystems, Foster City, CA, United States.<br />

Since the introduction <strong>of</strong> Sanger dideoxy sequencing, significant efforts<br />

have been directed toward increasing throughput by streamlining<br />

workflow. We describe here further enhancements for a PCR product<br />

resequencing workflow capable <strong>of</strong> reducing the total time, from beginning<br />

PCR reactions through completion <strong>of</strong> basecalling, to 6 hours or<br />

less. The workflow shown employs a new AmpliTaq Gold ® Fast PCR<br />

Master Mix in conjunction with modified thermal cycler conditions to<br />

substantially reduce the time required for PCR amplification. Process<br />

time is further reduced through optimization <strong>of</strong> cycle sequencing (BDT<br />

v1 .1) conditions . We have coupled these improvements with an efficient<br />

sequencing reaction cleanup protocol and decreased CE run<br />

time using the fast plates on a 3130xL . Overall data quality compares<br />

favorably with data obtained using previously documented methods .<br />

The increased efficiency and generation <strong>of</strong> high quality results is vital<br />

to both clinical and research applications in reducing time to discovery<br />

.<br />

P08.30<br />

Analysis <strong>of</strong> copy number variation using formalin-fixed paraffinembedded<br />

(FFPE) samples on BAc microarrays<br />

D. Postma, S. Snoeijers, M. Lacombe, S. Schoenmakers;<br />

Kreatech Diagnostics BV, Amsterdam, The Netherlands.<br />

Array-based comparative genomic hybridization (aCGH) has become<br />

a powerful tool to analyze DNA copy number changes . Especially in<br />

combination with archival tissue samples with well-documented follow-up<br />

data, it enables the analysis <strong>of</strong> genomic changes underlying<br />

tumour development . Unfortunately, DNA isolated from archival, formalin-fixed,<br />

paraffin-embedded (FFPE) material, is <strong>of</strong>ten degraded<br />

and therefore difficult to label. In theory, labelling techniques that skip<br />

the use <strong>of</strong> enzymes would be the best option . Therefore, we compared<br />

the non-enzymatic Universal Linkage System (ULS) and conventional<br />

random priming to label DNA isolated from FFPE material . Testing<br />

<strong>of</strong> FFPE samples that had been stored for up to 17 years showed

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!